Physician profile
Fernando Jimenez
NPI 1871531137
$6,721.58
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,589 · 2020: $873 · 2021: $1,323 · 2022: $919 · 2023: $1,001 · 2024: $15.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $972.49 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $734.11 | 2019-2023 | Jardiance |
| Glaxosmithkline, LLC. | $718.03 | 2019-2023 | Trelegy Ellipta |
| Lilly USA, LLC | $675.44 | 2019-2023 | Jardiance, Mounjaro, Emgality |
| Pfizer INC. | $610.95 | 2019-2023 | |
| Novo Nordisk INC | $572.58 | 2021-2023 | |
| Astrazeneca Pharmaceuticals Lp | $490.34 | 2019-2023 | Breztri |
| Novartis Pharmaceuticals Corporation | $436.85 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $428.62 | 2019-2023 | Verquvo |
| Amarin Pharma, INC. | $316.97 | 2019-2021 | |
| Amgen INC. | $242.91 | 2019-2023 | Evenity |
| Vanda Pharmaceuticals INC. | $155.72 | 2020-2023 | Hetlioz |
| Bayer Healthcare Pharmaceuticals INC. | $147.30 | 2022-2023 | |
| Abbott Laboratories | $65.09 | 2022-2024 | Proclaim, Freestyle Libre |
| Sanofi-Aventis U.S. LLC | $58.90 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $47.29 | 2019-2021 | |
| Exact Sciences Corporation | $24.39 | 2023 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $23.60 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.